comparemela.com


Gland Pharma Ltd Q3FY21 net profit at Rs. 204.10 crore
Posted On:
Gland Pharma Ltd has reported financial results for the period ended December 31, 2020.
Financial Results (Q3 FY20-21) - QoQ Comparison
The company has reported total income of Rs.894.54 crores during the period ended December 31, 2020 as compared to Rs.851.85 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.204.10 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.218.85 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.12.82 for the period ended December 31, 2020 as compared to Rs.14.12 for the period ended September 30, 2020.

Related Keywords

Arizona ,United States ,Srinivas Sadu ,Gland Pharma Ltd ,Time Zone ,Pharma Ltd ,Gland Pharma ,Net Profit ,அரிசோனா ,ஒன்றுபட்டது மாநிலங்களில் ,ஸ்ரீநிவாஸ் சாது ,சுரப்பி பார்மா லிமிடெட் ,நேரம் ஸோந் ,பார்மா லிமிடெட் ,சுரப்பி பார்மா ,நிகர ப்ராஃபிட் ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.